King Michael
- SEC CIK
- 0001998530
No open-market purchases or sales filed in the past year.
Current role at each company
- SABS SAB Biotherapeutics, Inc.CHIEF FINANCIAL OFFICERas of Feb 23, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists King Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 (view filing) | Nov 30 | Same day | King MichaelCHIEF FINANCIAL OFFICER | PPurchase | +5.00K | $0.90 | +$4.50K | New position5.00K after |